|
|
Volumn 48, Issue 10, 2003, Pages 1919-
|
|
Should octreotide be used cautiously in liver cirrhosis with concomitant congestive heart failure correlated to coronary artery disease?
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
FUROSEMIDE;
HEPATITIS B SURFACE ANTIGEN;
HISTAMINE H2 RECEPTOR ANTAGONIST;
LACTULOSE;
NEOMYCIN;
OCTREOTIDE;
SOMATOSTATIN DERIVATIVE;
SPIRONOLACTONE;
AGED;
ASCITES;
BLEEDING;
BRADYCARDIA;
BRAIN DISEASE;
CARDIOTOXICITY;
CASE REPORT;
CAUSE OF DEATH;
CONGESTIVE HEART FAILURE;
CORONARY ARTERY DISEASE;
CORRELATION ANALYSIS;
DIASTOLIC BLOOD PRESSURE;
ECHOCARDIOGRAPHY;
ESOPHAGUS VARICES;
FEMALE;
HEART EJECTION FRACTION;
HEART OUTPUT;
HEART RATE;
HEPATITIS;
HEPATORENAL SYNDROME;
HUMAN;
HYPOTENSION;
INOTROPISM;
JAUNDICE;
KIDNEY FAILURE;
LETTER;
LIVER BLOOD FLOW;
LIVER CIRRHOSIS;
LIVER ISCHEMIA;
LIVER METABOLISM;
LIVER NECROSIS;
MELENA;
OXYGEN SUPPLY;
PRIORITY JOURNAL;
VASOCONSTRICTION;
VEIN BLOOD FLOW;
AGED;
CORONARY DISEASE;
FATAL OUTCOME;
FEMALE;
GASTROINTESTINAL AGENTS;
HEART FAILURE, CONGESTIVE;
HUMANS;
LIVER CIRRHOSIS;
OCTREOTIDE;
VASOCONSTRICTOR AGENTS;
|
|
EID: 0345454725
PISSN: 01632116
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1026101816826 Document Type: Letter |
|
Times cited : (3)
|
|
References (3)
|
